The global Nuclear Medicine Market is expected to reach USD 24.9 Billion by 2030, at a CAGR of 24.9% during the forecast period 2022 to 2030.Radiopharmaceuticals are basically pharmaceutical formulations which include radioactive isotopes which are used in the field of therapeutics and diagnosis. They are simple as well as small substances which has radioactive substance that are used to treat cardiac, cancer, and neurological disorders.